canada semaglutide patent expiry Novo's Ozempic Expires Jan. 4 in Canada, But Generics Not Imminent Novo Nordisk takes legal action

The clinician should be aware, of course, of the severe CV morbidity burden that DM carries on, and be prepared to prevent heart failure by focusing on its early signs and initiating with SGLT-2 inhibitors particularly in patients at higher CV risk [110, 111]

Indeed, data from STEP-HFpEF and STEP-HFpEF DM trials have shown a significant reduction in inflammatory markers such as CRP with semaglutide compared with placebo 45,46

However, anecdotal reports from patients taking Ozempic have occasionally mentioned experiencing hiccups, particularly in online patient forums and social media discussions

Reduces major adverse cardiovascular events via direct cardiac and endothelial receptor signalling

Simple ways to talk to your clinician Bring clear questions to your visit

M., Birkenfeld A